| Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndrome D Rossi, M Cerri, D Capello, C Deambrogi, FM Rossi, A Zucchetto, ... British journal of haematology 142 (2), 202-215, 2008 | 306 | 2008 |
| Characterization and treatment of congenital thrombotic thrombocytopenic purpura F Alwan, C Vendramin, R Liesner, A Clark, W Lester, T Dutt, W Thomas, ... Blood, The Journal of the American Society of Hematology 133 (15), 1644-1651, 2019 | 148 | 2019 |
| Presenting ADAMTS13 antibody and antigen levels predict prognosis in immune-mediated thrombotic thrombocytopenic purpura F Alwan, C Vendramin, K Vanhoorelbeke, K Langley, V McDonald, ... Blood, The Journal of the American Society of Hematology 130 (4), 466-471, 2017 | 126 | 2017 |
| Frequent aberrant promoter hypermethylation of O6‐methylguanine‐DNA methyltransferase and death‐associated protein kinase genes in immunodeficiency … D Rossi, G Gaidano, A Gloghini, C Deambrogi, S Franceschetti, E Berra, ... British journal of haematology 123 (3), 475-478, 2003 | 56 | 2003 |
| Anti-ADAMTS13 autoantibodies against cryptic epitopes in immune-mediated thrombotic thrombocytopenic purpura E Roose, G Vidarsson, K Kangro, OJHM Verhagen, I Mancini, L Desender, ... Thrombosis and haemostasis 118 (10), 1729-1742, 2018 | 40 | 2018 |
| Prevalence and clinical characteristics of immune thrombocytopenic purpura in a cohort of monoclonal gammopathy of uncertain significance D Rossi, LD Paoli, S Franceschetti, D Capello, C Vendramin, M Lunghi, ... British journal of haematology 138 (2), 249-252, 2007 | 35 | 2007 |
| Usefulness of suPAR in the risk stratification of patients with sepsis admitted to the emergency department I Casagranda, C Vendramin, T Callegari, M Vidali, A Calabresi, ... Internal and emergency medicine 10, 725-730, 2015 | 32 | 2015 |
| von Willebrand factor/ADAMTS13 ratio at presentation of acute ischemic brain injury is predictive of outcome A Taylor, C Vendramin, D Singh, MM Brown, M Scully Blood advances 4 (2), 398-407, 2020 | 31 | 2020 |
| Pharmacokinetics of plasma infusion in congenital thrombotic thrombocytopenic purpura A Taylor, C Vendramin, S Oosterholt, O Della Pasqua, M Scully Journal of Thrombosis and Haemostasis 17 (1), 88-98, 2019 | 28 | 2019 |
| JAK2V617F in idiopathic venous thromboembolism occurring in the absence of inherited or acquired thrombophilia D Rossi, S Cresta, T Destro, C Vendramin, S Bocchetta, L De Paoli, ... British journal of haematology 138 (6), 813-814, 2007 | 27 | 2007 |
| Bethesda assay for detecting inhibitory anti-ADAMTS13 antibodies in immune-mediated thrombotic thrombocytopenic purpura C Vendramin, M Thomas, JP Westwood, M Scully TH Open 2 (03), e329-e333, 2018 | 26 | 2018 |
| A single‐center prospective study on the safety of plasma exchange procedures using a double‐viral‐inactivated and prion‐reduced solvent/detergent fresh‐frozen plasma as the … C Vendramin, S McGuckin, F Alwan, JP Westwood, M Thomas, M Scully Transfusion 57 (1), 131-136, 2017 | 23 | 2017 |
| Administration of immunoglobulin G‐degrading enzyme of Streptococcus pyogenes (IdeS) for persistent anti‐ADAMTS13 antibodies in patients with thrombotic thrombocytopenic … MJ Stubbs, M Thomas, C Vendramin, E Sonesson, C Kjellman, S Järnum, ... British journal of haematology 186 (1), 2019 | 19 | 2019 |
| Rituximab‐induced acute and delayed serum sickness in thrombotic thrombocytopenic purpura: the role of anti‐rituximab antibodies. C Vendramin, M Thomas, JP Westwood, S McGuckin, M Scully British Journal of Haematology 184 (5), 2019 | 19 | 2019 |
| Different patterns of NT-proBNP secretion in acute coronary syndromes S Ferraro, A Lupi, G Marano, L Rossi, L Ciardi, C Vendramin, G Bellomo, ... Clinica Chimica Acta 402 (1-2), 176-181, 2009 | 10 | 2009 |
| Indications of plasma exchanges in combination with intravenous immunoglobulins or therapeutic monoclonal antibodies. How to combine them? C Vendramin, M Scully La Presse Medicale 48 (11), 354-359, 2019 | 8 | 2019 |
| The prognostic value of plasma fibrinogen concentrations of patients with ST-elevation myocardial infarction and treated by primary percutaneous coronary intervention: A … S Ferraro, M Santagostino, G Marano, E Colli, C Vendramin, S Maffé, ... Scandinavian Journal of Clinical and Laboratory Investigation 72 (5), 355-362, 2012 | 8 | 2012 |
| Monitoring of cytomegalovirus reactivation during induction and nontransplant consolidation of acute leukemia M Lunghi, P Riccomagno, L De Paoli, C Vendramin, A Conconi, ... American journal of hematology 84 (10), 697-698, 2009 | 6 | 2009 |
| Ultra-sensitive troponin I levels to exclude acute myocardial infarction from myocardial injury S Ferraro, P Boracchi, M Santagostino, G Marano, C Vendramin, L Rossi, ... Clinical chemistry and laboratory medicine 50 (1), 159-166, 2012 | 5 | 2012 |
| Histogenesis and Pathogenesis of Primary Breast Lymphoma. D Rossi, E Berra, M Marino, D Capello, M Cerri, C Deambrogi, ... Blood, The Journal of the American Society of Hematology 104 (11), 1371-1371, 2004 | 4 | 2004 |
